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ABSTRACT The energetics and partition of two hybrid peptides of cecropin A and melittin (CA(1–8)M(1–18) and CA(1–7)M(2–9))
with liposomes of different composition were studied by time-resolved ﬂuorescence spectroscopy, isothermal titration calo-
rimetry, and surface plasmon resonance. The study was carried out with large unilamellar vesicles of three different lipid com-
positions: 1,2-dimyristoil-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DMPG),
and a 3:1 binary mixture of DMPC/DMPG in a wide range of peptide/lipid ratios. The results are compatible with a model
involving a strong electrostatic surface interaction between the peptides and the negatively charged liposomes, giving rise to
aggregation and precipitation. A correlation is observed in the calorimetric experiments between the observed events and
charge neutralization for negatively charged and mixed membranes. In the case of zwitterionic membranes, a very interesting
case study was obtained with the smaller peptide, CA(1–7)M(2–9). The calorimetric results obtained for this peptide in a large
range of peptide/lipid ratios can be interpreted on the basis of an initial and progressive surface coverage until a threshold
concentration, where the orientation changes from parallel to perpendicular to the membrane, followed by pore formation and
eventually membrane disruption. The importance of negatively charged lipids on the discrimination between bacterial and
eukaryotic membranes is emphasized.
INTRODUCTION
The increasing prevalence of multiresistant microbial strains
is driving extensive research for new type of antibiotics
(1–5). Among these, antimicrobial peptides (AMP) have
been widely studied in past years, as they may become an
alternative to conventional antibiotic therapy (2,6–17). In
fact, it has been claimed that cationic antimicrobial peptides
exploit fundamental features of the bacterial cell so that re-
sistance is much less likely to evolve than in the case of
conventional antibiotics (7,18–20).
Over the years, efforts have been directed toward the
increase in potency and specificity of AMPs against path-
ogenic agents while minimizing their cytotoxic effect to-
ward eukaryotic cells. One particularly successful approach
is based on hybrid sequences or chimera, derived from
naturally occurring a-helical AMPs cecropin A (CA) and
melittin (M), which provided the first examples of AMP
sequence hybridization (21,22). One such hybrid peptide,
CA(1–8)M(1–18), showed improved antimicrobial activity
relative to parent cecropin A and greatly reduced the he-
molytic properties of melittin (23). Taking CA(1–8)M(1–
18) as the lead, a subsequent approach was to further reduce
the size of the hybrid CA-M peptides while retaining anti-
microbial activity. This led to CA(1–7)M(2–9), a pentade-
capeptide that preserves most of the activity of the parent
lead peptide (24).
Their amino acid sequences are shown in Table 1, along
with their helical wheel and b-sheet projections in Fig. 1.
Both hybrids share the cationic N-terminus of cecropin A
followed by the hydrophobic N-terminus of melittin, but
CA(1–8)M(1–18) has a larger hydrophobic domain than
CA(1–7)M(2–9).
Both CA(1–8)M(1–18) and CA(1–7)M(2–9) have been
extensively studied in terms of antimicrobial activity (25–
31), as well as on their membrane interaction properties
(6,28–33). The characteristics of the peptide-membrane inter-
action process are dependent on the charge properties of the
membrane and can be used to interpret the specificity of
peptide activity against pathogens (12,18,29,34–39).
Following our previous study with these peptides, where
their effect on vesicle thermotropic phase behavior, charge,
and size could be related to membrane-induced changes in
peptide structure (6), we have now addressed the energetics
of the interactions as well as the partition of the peptides to
the membranes and their relative position depending on
peptide concentration.
Large unilamellar vesicles (LUVs) of three different lipid
compositions were used: zwitterionic 1,2-dimyristoyl-sn-
glicero-3-phosphocholine (DMPC), anionic 1,2-dimyristoyl-
sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), and a
DMPC/DMPG (3:1) mixture. The study was carried out by
time-resolved fluorescence spectroscopy (TRFS), isother-
mal titration calorimetry, and surface plasmon resonance
(SPR).
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MATERIALS AND METHODS
Materials
DMPC and DMPG were obtained from Avanti Polar Lipids (Alabaster, AL)
and used without further purification. Fmoc-protected amino acids, coupling
reagents, and resins for solid-phase peptide synthesis were purchased from
Bachem (Weil am Rhein, Germany). All other reagents were from Sigma
Chemical (St. Louis, MO).
Peptide solutions and liposome suspensions were prepared in HEPES
buffer (N-(2-hydroxyethyl) piperazine-N9-ethane-sulphonic acid). Ultra pure
water (Milli Q Gradient, Millipore, Billerica, MA) was used in the prepa-
ration of all samples.
Vesicle preparation
Appropriate amounts of phospholipids (DMPC, DMPG, and DMPC/DMPG
(3:1)) were dissolved in chloroform (DMPC) or chloroform/methanol (3:1 v/v)
(DMPG and DMPC/DMPG (3:1)). The samples were then dried under a
nitrogen stream, and the film was kept under vacuum for 3 h to remove all
traces of organic solvents. The resulting lipid film was warmed together with
HEPES buffer (10 mM Hepes, 100 mM NaCl, pH 7.4) in a thermostated
water bath at ;10C above the temperature of the gel-to-liquid crystalline
phase transition (Tm), and then hydrated at the same temperature. The
multilamellar vesicles thus obtained were frozen in liquid nitrogen and
thawed in a water bath at ;10C above Tm, and this process was repeated
five times.
Large unilamellar vesicles (LUVs) were obtained from the multilamellar
vesicles by extrusion in a 10 mL stainless steel extruder (Lipex Biomem-
branes, Vancouver, British Columbia, Canada), thermostated with a re-
circulating water bath, at;10C above Tm. The samples were passed several
times through polycarbonate filters (Nucleopore, Pleasanton, CA) of de-
creasing pore size (600, 200, and 100 nm—5, 5, and 10 times, respectively),
under inert (N2) atmosphere.
Size distribution of extruded vesicles was determined by dynamic light
scattering (Zetasizer nanoZS, Malvern Instruments, Malvern, Worcester-
shire, UK) at 37C, using a He-Ne laser (wavelength 633 nm) as a source of
incident light, and operating at a scattering angle of 173. Mean particle size
was thus determined as being of (106 6 4) nm (average and standard de-
viation of six independent measurements). The phospholipid concentration
was determined by the phosphomolibdate method (40).
Peptides synthesis and solution
The studied peptides, CA(1–7)M(2–9) and CA(1–8)M(1–18), were synthe-
sized as C-terminal carboxamides by Fmoc/tBu solid phase strategies, pu-
rified, and characterized by methods as those described in Gomes et al. (41).
Peptide stock solutions were prepared in HEPES buffer (10 mM; 0.1 M
NaCl; pH 7.4) in the 2–5 mM concentration range, and quantitated by either
amino acid analysis (AAA) or ultraviolet absorption at 280 nm, taking 5690
M1.cm1 as the molar extinction coefficient corresponding to the single
tryptophan residue present in both studied peptides (42).
Time-resolved ﬂuorescence spectroscopy
Stock solutions (6 mM) of LUVs of the three membrane systems (DMPC,
DMPG, and DMPC/DMPG) were prepared in the buffer as above. Unless
otherwise stated, the concentration of the peptide solutions in the same buffer
was 20 mM. Addition of appropriate volumes of liposome suspension into
the peptide solution was performed so as to cover a range of liposome
concentrations (0–6 mM). Measurements were performed for the pure pep-
tide solution and at increasing liposome concentration. The mixtures were
prepared (six independent mixtures for each peptide/membrane system) and
allowed to equilibrate at 35C for ;1/2 h before measurements. All mea-
surements were performed at 35C.
Fluorescence decay measurements were carried out with a single-photon
timing system, which is described elsewhere (43). Sample was excited at 295
nm using a frequency doubled, cavity dumped (3.7 MHz repetition rate), dye
laser of rhodamine 6G (Coherent (Santa Clara, CA) 701-2), synchronously
pumped by a mode-locked Ar1 laser (514.5 nm, Coherent Innova 400-10).
The emission (at 316 nm) was detected by a Hamamatsu (Bridgewater, NJ)
R-2809 MCP photomultiplier at 345 nm (Jobin-Yvon (Edison, NJ) HR320
monochromator). Timescales were chosen for each sample to observe the
decay through 2–3 intensity decades. Experimental response functions for
deconvolution were generated from a scattering dispersion (silica, colloidal
water suspension, Aldrich, Milwaukee, WI). Data analysis was carried out
using a nonlinear least squares iterative convolution method based on the
Marquardt algorithm. The goodness of the fits was judged from the experi-
mental x2 values, weighted residuals, and autocorrelation plots.
The complex decay of tryptophan was described by a sum of exponen-
tials,
IðtÞ ¼ +
n
i¼1
aie
t=ti ; (1)
where ai and ti are the normalized amplitude (+iai ¼ 1) and lifetime of the
ith decay component, respectively.
From the fluorescence intensity decay kinetics of Trp residues, the am-
plitude-weighted mean fluorescence lifetime, t; (also called the lifetime
weighted quantum) was calculated as
t ¼ +
n
i¼1
aiti: (2)
TABLE 1 Sequences of cecropin A, melittin, and the hybrid peptides CA(1–7)M(2–9) and CA(1–8)M(1–18)
Peptide Sequence
Cecropin A H-KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAKK-NH2
Melittin H-GIGAVLKVLTTGLPALISSWIKRKRQQ-NH2
CA(1–7)M(2–9) H-KWKLFKKIGAVLKVL-NH2
CA(1–8)M(1–18) H-KWKLFKKIGIGAVLKVLTTGLPALIS-NH2
FIGURE 1 Helical wheel representation of CA(1–7)M(2–9) and CA(1–
8)M(1–18): light gray, polar, noncharged residues; dark gray, polar, posi-
tively charged residues; and white, hydrophobic residues.
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Determination of partition constants
The association of the peptides to the model membranes can be described
quantitatively as a first approximation in terms of a simple partition equi-
librium between the aqueous and the lipid bilayer phase for amphipathic
peptides, P,
KP;x ¼
n
P
L
nl1 n
P
L
n
P
W
nw1 n
P
W
; (3)
where KP;x represents the mole-fraction partition coefficient of the peptide,
nW and nL are the amount (in mole) of water and lipid in each sample, and
nPi is the amount of peptide present in each phase (i ¼ W, aqueous phase,
and i ¼ L, lipid phase, respectively). In all partitioning experiments, it is
reasonable to assume that nW  nPW, and because high membrane-bound
concentrations of the peptide are usually avoided to prevent deviations
from ideal partitioning due to peptide/peptide interactions at the water/
membrane surface or in the lipid bilayer, it can also be considered that
nL  nPL: In these circumstances, Eq. 3 can be simplified:
KP;x ¼
n
P
L
nl
n
P
W
nw
: (4)
If the amounts of lipid and water (nW and nL, respectively) are replaced by
their respective volumes, a partition constant (KP) related to the previous one
is obtained, being
KP ¼ KP;xgW
gL
; (5)
where gw and gL are the molar volumes of water and lipid. This second form
of the partition constant was used.
The changes undergone by the peptides’ fluorescence properties can be
used to distinguish between free and membrane-bound peptide populations
by time-resolved fluorescence measurements (fluorescence decays), and
therefore can be applied to quantitatively evaluate its interaction with the lipid
bilayers. Therefore, by use of the equations above, an equation relating the
lifetime-weighted quantum yield,t; to the partition coefficient can be derived:
t ¼ tW1KP3 gL3 ½L3 tL
11KP3 gL3 ½L
: (6)
This equation was fitted to the experimentally obtained data to get the
partition coefficient of the peptide to the membrane, KP, and the lifetime-
weighted quantum yield in the membrane phase, tL: Although fluorescence
steady-state data could be used for this purpose, in the strongly scattering
solutions used, no reasonable fittings would be obtained. The integration of
the decay, which is proportional to the quantum yield, is a much more reliable
experimental approach. The lipid concentration was based on the outer-
leaflet content (50% of total lipid content).
Isothermal titration calorimetry
The calorimetric technique used was stepwise isothermal titration microcal-
orimetry. The water bath and peripheral units were built at Lund University,
Lund, Sweden, and a twin heat conduction calorimeter (ThermoMetric,
Ja¨rfa¨lla, Sweden) was used with a 1 mL titration cell equipped with a gold
stirrer. The instrument was calibrated electrically, using an insertion heater.
The detailed calorimetric setup and basic procedure have been described
previously (44). Briefly, in each titration, 0.9848 6 0.0008 mL of sample
(either liposome suspension or peptide solution) were placed in the titration
cell and sequences of successive injections were made at 4 min intervals
(injections with 20 min intervals did not reveal the presence of slow reactions).
The temperature of the measurements was 35C throughout, so that the re-
corded values refer to the interaction of the peptides with the liposomes in
the fluid phase (6). Experiments were performed in the ‘‘fast titration mode’’,
the resulting curves deconvoluted (45) and the integrals were calculated in
V.s, and transformed to heat exchanged by the appropriate calibration con-
stant. The obtained heats were corrected for the dilution effects as determined
in separate experiments (they were only significant in the case of the titration
of highly concentrated peptide solution into buffer).
Different experimental setups were used, regarding the relative positions
of the peptides and the vesicles:
1. Very low peptide/lipid (P/L) ratios (;1:1500 or 1:3000)—injections of
12.46 mL peptide solution (1.7 mM for CA(1–7)M(2–9) and 0.72 mM
for CA(1–8)M(1–18)) into liposome suspension in the cell (35 mM).
2. Intermediate P/L ratios (P/L from 1:333 to 1:14)—injections of 2.66 mL
peptide solution (5.38 mM) into liposome suspension in the cell (5.85
mM). This setup was only used for CA(1–7)M(2–9) with DMPC (see
below).
3. Very high P/L ratios (1:2–1:33)—injections of 2.66 mL liposome
suspension (35 mM) into peptide solution in the cell (20–50 mM).
Surface plasmon resonance
SPR analyses were run on a Biacore 3000 (Biacore, Uppsala, Sweden) using
L1 sensor chips (Biacore) for vesicle (LUVs) capture and subsequent for-
mation of the lipid bilayer (46,47). Phosphate-buffered saline (PBS,100 mM
at pH 6.81) was used as running buffer and to prepare the peptide solutions as
well. Other buffers (e.g., HEPES) were tested, but led to higher baseline
drifts. All peptide solutions were freshly prepared, buffer degassed, and fil-
tered through a 0.22 mM filter. Before liposome immobilization and inter-
action analysis, the L1 sensor chips were rinsed with running buffer and then
washed with a 25-mL injection of 40 mM N-octyl-b,D-glucopyranoside
(OG) at a flow rate of 5 mL/min. LUVs (1 mM in PBS) were then injected
(30 mL) at a 2 mL/min flow rate, after which the surface was rinsed with 50
mL of 10 mM NaOH at a flow rate of 50mL/min to remove any multilamellar
structures from the lipid surface (46,47). This procedure reproducibly led to
the desired lipid bilayers with stable baseline signals. Peptide-lipid binding
assays were performed through sequential injections of peptide solutions in
PBS at four different concentrations, ranging from 12.5 to 100 mM, using a
10 mL/min buffer flow rate to avoid mass-transport limitations. Once the
injection had ended, the buffer flow was continued to allow for a dissociation
period of 450 s. As the initial baseline level was not recovered after this
dissociation step, and not even after washing the surface with NaOH (50 mL)
and HCl (50mL) at 50mL/min, the lipid bilayer was stripped out with a 30-mL
injection of OG (at 5 mL/min) after each peptide injection and the liposome
immobilization was repeated before the subsequent injection. The sensor-
grams obtained for each peptide-lipid interaction were tentatively processed
by curve fitting with numerical integration analysis, using the BIA evaluation
3.0.1 software. This study was done at 25C and 35C, and all analyses were
run in duplicate.
RESULTS AND DISCUSSION
Partition constants and life-time weighted
quantum yields
The results obtained for both peptides and the three lipid
systems are plotted in Fig. 2, A and B, for CA(1–7)M(2–9)
and CA(1–8)M(1–18), respectively. Equation 6 was fitted to
the experimental results, representing a model that considers
a simple partition for the peptide between the aqueous media
and the membrane. Some peculiarities were observed for
both peptides.
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In the case of CA(1–7)M(2–9), the results with DMPC and
DMPG are compatible with such a model under the condi-
tions used, as can be seen in Fig. 2 B, where the obtained
fitted lines are represented along with the experimental data.
The fittings were performed with the lipid content based on
the outer leaflet, i.e., half of the total lipid content. The ob-
tained Kp values were (2.96 0.6)3 10
3 and (10.66 1.5)3
103 and the corresponding values of the lifetime-weighted
quantum yield in the membrane phase, t
L
; were (3.016 0.09)
and (1.87 6 0.01) ns for DMPC and DMPG, respectively.
For the mixed system, on the other hand, it was impossible
to fit a curve reflecting a simple partition to the observed
results—a very strong partition is observed until ;8%
(peptide mol percentage) (based on the outer leaflet), and
after that the lifetime-weighted quantum yield decreases. In
Fig. 2 B, the obtained results for this system are connected by
a broken line. If a fitting is performed by using just the first
three values to get an insight into the magnitude of the par-
tition in the initial part (high P/L ratios), a Kp value of 1.0 3
105 is obtained. This value indicates a very strong partition to
the mixed membrane at the initial stage of the fluorescence
experiments. A curve was simulated using the first (value in
buffer) and last points for comparative purposes, and the best
parameters were Kp ¼ 1.3 3 104 and tL ¼ 2.6. These values
are both intermediate to the respective values found for the
pure DMPC and pure DMPG systems.
For CA(1–8)M(1–18), the most remarkable feature was
that in most cases the observed value for the lifetime-weighed
quantum yield in buffer was higher than the corresponding
values obtained in the presence of the membranes (Fig. 2 A).
As we had previous knowledge that this peptide adopts a
b-sheet structure—probably antiparallel—in buffer (6), we
suspected that this indicates a strong association leading to a
shielding of the Trp from the aqueous environment, even at
the low peptide concentrations initially used (20 mM). The
results from anisotropies also confirm a strong association
(results not shown). Measurements of the peptide in buffer
were performed at progressively lower peptide concentra-
tions, leading to decreasing values of lifetime-weighed
quantum yield, until a value of 1.86 ns was obtained at 3 mM
(this was the lower limit that could be determined). There-
fore, calculations were performed also allowing the lifetime-
weighed quantum yield in buffer to be obtained as a fitting
parameter, leading to a value of tw of 1.56 ns. This value was
then used as a fixed parameter in all three fittings, producing
Kp values of (36.1 6 9.8) 3 10
3, (13.3 6 1.6) 3 103, and
(13.9 6 1.7) 3 103, and t
L
values of (2.07 6 0.02), (3.26 6
0.04), and (2.526 0.03) ns for DMPG, DMPC, and DMPC/
DMPG (3:1), respectively.
These results are summarized in Table 2, along with the
enthalpies obtained from calorimetry and the thermodynamic
parameters DG and TDS derived thereafter (see below).
Energetics of the interaction
Type 1 experiments (very low P/L ratios, see above), where
small aliquots of peptide solution were titrated into concen-
trated liposome suspensions, produced a constant heat release
FIGURE 2 Plot of the obtained values of t;
the amplitude-weighted mean fluorescence life-
time (Eq. 2), as a function of lipid concentration
(outer leaflet, see text), for the three studied
systems, at 35C. The symbols represent the
experimental values, and the lines are the fitted
curves according to Eq. 6. (Symbols) (:)
DMPC, (d) DMPC/DMPG (3:1), and (n)
DMPG. (*) represents the experimental value
for tw for CA(1–8)M(1–18) at concentration of
20 mM. The open symbol was obtained from
model fitting (see text for details). (Lines)
DMPC (solid), DMPC/DMPG (3:1) (dashed),
and DMPG (dotted). (A) CA(1–8)M(1–18); (B)
CA(1-7)M(2–9) Note that in B, the broken line is not a fitted line, it just connects the experimental points. The values represented close to the experimental
points are the peptide percent (based on the lipid content of the outer layer (see text)).
TABLE 2 Thermodynamic parameters for the interaction of the two peptides with the different membrane systems at 308.15 K,
as obtained from calorimetry and TRFS
DH/(kJ/mol) Kp* DG/(kJ/mol) TDS(/kJ/mol) tL/ns*
DMPG CA(1–7)M(2–9) 46 6 4 (1.06 6 0.15) 3 104 33.1 12.9 1.87 6 0.01
CA(1–8)M(1–18) 43 6 4 (3.61 6 0.98) 3 104 36.3 6.7 2.07 6 0.02
DMPC CA(1–7)M(2–9) – (2.90 6 0.5) 3 103 29.8 – 3.01 6 0.09
CA(1–8)M(1–18) 15 6 2 (1.33 6 0.16) 3 104 33.7 18.7 3.26 6 0.04
DMPG/DMPC CA(1–7)M(2–9) – – – –
CA(1–8)M(1–18) – (1.39 6 0.17) 3 104 –33.8 – 2.52 6 0.03
*From TRFS.
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per injection when DMPG was involved, indicating that at
these low ratios the partition of both peptides to the nega-
tively charged membrane is almost complete. To calculate
the correct value for the respective enthalpies of interac-
tion, the obtained results were nevertheless corrected by
use of the partition coefficients obtained from TRFS Kp,
(see below). The peptide partition to the negatively charged
membrane under these conditions was 99.6% and 99.9%
for CA(1–7)M(2–9) and CA(1–8)M(1–18), respectively.
The obtained enthalpy values were (46 6 4) and (43 6
4) kJ/mol(peptide in the membrane) for CA(1–7)M(2–9) and
CA(1–8)M(1–18), respectively. The estimated precision
of the enthalpy values was .10%, thus the enthalpy of in-
teraction of both peptides with DMPG is the same, within
experimental uncertainty.
Our partition coefficient can be easily transformed into the
mole fraction partition coefficient (see Eq. 5 above), asKp,x¼
Kp3 (gL/gW), using the values 0.698 and 0.018 L/mol for the
molar volumes of lipid and water (48), respectively, and the
Gibbs energy change and entropy change can therefore be
calculated as DG ¼ RT ln(Kp,x 3 38.8) and TDS ¼ DH 
DG. The Gibbs energy values so obtained were 33.1 and
36.3 kJ/mol, and the entropies, TDS 12.9 and 6.7 kJ/
mol, for CA(1–7)M(2–9) and CA(1–8)M(1–18), respectively
(Table 2).
Although with the pure negatively charged system the
most important factor underlying the interaction is electro-
statics, and both peptides have the same charge, this simi-
larity in enthalpy and Gibbs energy changes for two peptides
that are significantly different in length must also reflect that a
different number of amino acids participates in the helical
structure formed upon interaction with the membrane. It is
known that the energetics of the transition from a random coil
in solution to an a-helix or a b-sheet in the membrane is
consistent with the hypothesis that secondary structure for-
mation at the membrane is driven by a reduction in the Gibbs
energy of partition due to hydrogen bonding among the
peptide amide groups (49,50). Furthermore, apparently it
does not depend much either on the peptide or on the sec-
ondary structure type—Ladokhin and White found the
DGresidue for melittin a-helix formation at the POPC mem-
brane interface to be similar to the value observed for b-sheet
formation by AcWL5COO
, thus suggesting the value of
DGresidue  2 kJ/molres for estimating the energetic con-
sequences of secondary structure on membranes (50). We
can therefore compare our thermodynamic parameters with
available data for other peptides. Although in most studies
mixed membranes are used, there are some reports with pure
negatively charged liposomes, such as the study by Ladokhin
and White of the partition of native melittin and its diaster-
oisomer D4,L-melittin (50). Wieprecht et al. (51) studied the
energetics and partition of magainin-2-amide to LUVs of
POPC/POPG (3:1) at 30C and suggested the contribution of
helix formation to the enthalpy of binding to be 3.3 kJ per
mol of residues in the helix, and a contribution of helix for-
mation to the total Gibbs energy of 0.5 kJ/molres. Even
though we have a purely negative membrane, the energetics
at very low P/L ratios are dominated by electrostatics, i.e.,
by the interaction with the negative parts of the membrane,
as we will show later in this discussion. Therefore, we can
use their equation to predict the contribution of the enthalpy
of helix formation to the total enthalpy for each of our pep-
tides. Bargava and Feix (32) reported results for the partition
of CA(1–7)M(2–9) to LUVs of POPE/POPG (80:20) and
POPE/POPG/CL (68:26:6) membranes, also at high ionic
strength (20 mM MOPS and 100 mM KCl, pH 7.0), and low
P/L ratios. Their results were compatible with the formation
of a single a-helix that encompasses the full length of the
peptide, although the evidence for helical structure in the
N-terminal half was less rigorous. Circular dichroism mea-
surements showed that this peptide has a random structure
in buffer, and no significant difference in the curves was
found for this membrane system (DMPG) when the peptide
content varied from 3 to 8 mol%, indicating a 78% helicity in
these conditions (M. Bastos, unpublished data). Therefore,
the initial estimate by Bargava and Feix (32) was probably
too high—in fact, they recently reported (33) a smaller value
(58%) in LUVs of POPE/POPG/CL (70:25:5) in 50 mM
MOPS, pH 6.8 (unadjusted ionic strength). Taking our own
estimation of 78%, the calculated value is 38 kJ/mol (153
0.78 3 (3.3)). This calculated value for the contribution
of helix formation to the observed enthalpy thus represents
85% of our experimental value. This is very similar to the
value of ;90% found by Wieprecht et al. for the partition
of PGLa to POPC/POPG (3:1) membranes at 30C, and
the difference even goes along with a reduction in helix
content as the temperature increases (our values are at 35C,
and they found that this contribution decreases to 68% at
45C) (52).
As regarding CA(1–8)M(1–18), we can estimate a helix
content for our DMPG system of ;40%, and we found this
peptide to have a significant b-sheet structure in buffer (6).
Ladokhin and White (50) also observed that melittin does not
form a helix encompassing all residues in negatively charged
membranes—they found a mean helical content of 71%
when melittin partitions to LUVs of POPG, a value that is
higher than our estimate for CA(1–8)M(1–18). The contri-
bution of helix formation to the measured enthalpy would
then amount to 34 kJ/mol (26 3 0.4 3 (3.3)) for this
peptide, representing 80% of the measured enthalpy. This
value is similar to the one found for the smaller peptide. We
should stress, though, that in this case, the enthalpy change
must also reflect partly the change from a partial b-sheet
structure in buffer to an a-helix at the membrane surface.
Indeed, this amounts to saying that the measured enthalpies
for peptide partition to a DMPG membrane mainly reflect the
formation of an a-helix at the negatively charged surface.
When the peptides were titrated into concentrated DMPC
solutions under the same conditions (very low P/L ratios),
two different situations occurred: i), in the case of CA(1–8)
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M(1–18), a constant heat release was also observed, from
which the interaction enthalpy was calculated, using again
the partition coefficient obtained from TRFS (see above) to
calculate the amount of peptide that partitions to the mem-
brane (99.6%)—the value so obtained was (15 6 2) kJ/
mol(peptide in the membrane); and ii), with CA(1–7)M(2–9), it was
never possible to get a constant heat release, no matter how
we changed and reduced the peptide concentration (within
instrument sensitivity). The observations with CA(1–7)M(2–
9) led us to use another set of P/L ratios (type 2 experiments),
where a solution of peptide 5.85 mM (v ¼ 12.46 mL) was
titrated into a DMPC suspension of concentration 5.85 mM,
so as to fully investigate the behavior of this peptide with
zwitterionic membranes in a very large P/L range. The
obtained raw data for the type 2 setups can be seen in Fig. 3,
A–C. Fig. 3 A shows the calorimetric raw data for the titration
of a 1.7 mM peptide solution into a 31.85 mM DMPC sus-
pension. We can see that the first five injections give rise
to a positive effect: at the fifth injection, a negative contri-
bution starts to appear (P/L¼ 1:270), the net heat exchange is
zero at the eighth injection (P/L ¼ 1:170), and from ninth
injection through the end of the titration run a negative heat
effect is recorded (P/L from 1:150 to 1:90). In Fig. 3 B, we
show a plot of the calorimetric tracing for the second set of
experimental conditions, with an enlargement of the first six
injections presented in Fig. 3 C. In this last one, we can see
that the first injection gives rise to an endothermic peak: from
second (P/L ¼ 1:184) to fifth (P:L ¼ 1:74) injections, there is
first a fast exothermic process that is followed by an endo-
thermic one, and as the titration proceeds, the endothermic
contribution decreases and the exothermic one increases,
until eventually the endothermic contribution disappears
from injection 6 (P/L ¼ 1:61) to the end of the titration.
The integrated results were corrected for peptide dilution
into buffer (small endothermic effect), as titration of buffer
into the liposome suspension did not give rise to a significant
heat effect. In Fig. 4, the corrected heats are plotted as a
function of peptide % (100*molpeptide/mollipid) for both types
of experiments—titration into 35 mM DMPC (usual setup)
and the type 2 setup just described above. In both cases, we
can see that there is a heat release throughout the titration, but
the curve growth depends on the P/L. Please note that the
different slopes of the descending parts from both the titration
setups reflect a different increase in the P/L ratio per injec-
tion. In both cases, the first injection(s) gave rise to a small,
endothermic effect that turns negative at ;0.55% (peptide
percentage) or 1:180 (P/L ratio). In the curve with interme-
diate P/L ratios (setup 2 above), and always referring to a
total lipid content, we can see that there is an increasingly
larger heat release per injection until a P/L ratio of 1:40; then
a plateau region is observed until ;1:28, and thereafter
the heat release is decreasingly negative. If we consider
the injections that only give rise to a positive heat effect (first
four injections when we titrate a 1.7 mM peptide solution into
a 35 mM liposome suspension and the first injection for the
FIGURE 3 (A) Raw data (potential difference across the thermopiles as a
function of time) for the titration of CA(1–7)M(2–9) (c ¼ 1.7 mmol/dm3)
into DMPC suspension in the vessel (c ¼ 31.85 mmol/dm3). The injected
volume was 12.46 mL per injection. (B) Raw data (potential difference
across the thermopiles as a function of time) for the titration of CA(1–
7)M(2–9) (c ¼ 5.38 mmol/dm3) into DMPC suspension in the vessel (c ¼
5.85 mmol/dm3). The injected volume was 2.66 mL per injection. (C)
Enlargement of the first six injections of the previous titration curve.
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titration of 5.38 mM peptide into 5.85 mM liposome sus-
pension), the enthalpy obtained either from the average of the
first four injections or the single injection in the second case
both produce a positive enthalpy value of 15 kJ/mol, cor-
responding in both cases to a maximum of 0.3% peptide. This
heat pattern leads us to propose that this value can be tenta-
tively assigned to the partition of CA(1–7)M(2–9) to the
zwitterionic membrane without conformational transition to
an a-helix—that is, it represents the partition of the random
coil from bulk solution to the membrane surface.
As can be inferred from what is described above, the
partition profile of CA(1–7)M(2–9) to DMPC represents a
very interesting case study, worthy of further discussion.
Turning our attention to Fig. 3 (squares and solid line), we
see that after crossing zero at ;0.6% (peptide molar per-
centage) (1:180), there is an increasingly negative heat re-
sponse as the peptide content increases, until 2.5% (1:40).
Analyzing the descendant and ascendant parts of the titration
curve, we observe that whereas the heat release per injection
is not constant within each part, its derivative is—the average
increment on the descending part (until 2.5% (1:40)) is0.136
0.06 mJ and on the ascending part it amounts to (10.05 6
0.02) mJ. On the descending part, this must be the reflection
of a cooperative uptake. If we divide the decrement observed
in the descendent part by the increase in peptide number of
moles, we will get the value9.2 kJ/mol. This is a reasonable
value as compared to that of 15 kJ/mol obtained for the
partition of CA(1–8)M(1–18) to DMPC. Nevertheless, it
reflects a different behavior, as here it represents the increase
in enthalpy per mole of peptide. Again, this cooperative be-
havior is in line with similar observations for this peptide
already referred to above (32,33). Ferna´ndez et al. (53) have
also found evidence for association of CA(1–7)M(2–9) in
helix-inducing solvents, and suggested that aggregation of
the helical peptide in membranes could result in an increase
in its effective partition. Our plateau value occurs between
2.5% (1:40) and 3.5% (1:30), in remarkable agreement with
the range where Pistolesi et al. (33) also found a plateau.
Their sharp decrease at 1:25 is also almost the same value as
ours, where the observed heat release starts to decrease.
If we consider the initial study of Bhargava and Feix for
very low peptide content (32), we can assume that we also
have CA(1–7)M(2–9) in the beginning of the titration as an
a-helix parallel to the membrane surface. Our FTIR results
(not shown), on the other hand, indicate that already at 1%,
there is a transmembrane helix. Nevertheless, we should
stress that in the FTIR measurements, we have only a lipid
monolayer with minimal hydration, and thus the results can
differ from what is observed in liposome suspensions, as it
has been already referred that melittin orientation in a
membrane depends critically on the hydration level. This
shows that our peptide can change from parallel to perpen-
dicular to the membrane surface already at low peptide
content. It has been reported that CA(1–7)M(2–9) is not long
enough to span the whole length of the bilayer when in helical
form (54), as the length of the a-helix of a 15-residue analog
is ;22.5 A˚. This can be the reason for the cooperative up-
take—the need for two helices to span the lipid bilayer can
promote a higher peptide partition. After 3.5%, the heat re-
lease starts to decrease. As pore formation is known to be an
endothermic process, we propose that this decrease reflects
pore formation. In this line of reasoning, the plateau value can
be tentatively interpreted as reflecting a range of P/L ratios
where we are close to membrane saturation and there is a
balance between peptide partition and pore formation.
After the threshold value of 3.5%, pore formation in-
creases at every rise in peptide content. A maximum in the
dichroic ratio for the peptide amide I was also observed in the
FTIR measurements for 3% peptide, with a decrease there-
after to close to the initial values. It was further noted that at
all studied peptide contents (from 1 to 10%), the value for the
dichroic ratio for the lipid carbonyl was rather constant, and
the lipid showed a remarkable order in the presence of growing
amounts of peptide (M. Bastos and E. Goormaghtigh, un-
published results). This observation is in line with what was
found by Pistolesi et al. (33), where they point out that, as the
peptide concentration increased, the lipid systems reverted to
a behavior similar to that observed in the absence of peptide.
They interpret their results as possibly meaning that, after a
threshold concentration, the peptide becomes sequestered
(i.e., in localized pores), leaving the bulk lipid phase rather
unperturbed.
We agree with this view, and extend it further as we believe
that this segregation occurs early (indicated by a very high
and constant lipid ordering as suggested by FTIR), and is
responsible for the cooperative uptake. Probably in this pure
zwitterionic membrane, only transient toroidal pores are first
observed, whereas after 3% more permanent ones are formed.
One could also think of membrane solubilization as the final
stage of membrane disruption. Nevertheless, this contradicts
the return to unperturbed behavior observed by Pistolesi et al.
(33) and ourselves by FTIR. So we tend to find more realistic
the first explanation as it encompasses all known results.
Now looking at the ascendant part of the titration curve, we
find that again only the derivative of the heat as a function of
concentration is constant, namely at (10.05 6 0.02) mJ.
Dividing this value by the increase in the number of moles of
peptide per injection, we get the value of 13.5 kJ/mol. We
would tentatively assign this value to the enthalpy of pore
formation for this system. This value is smaller than the one
proposed by Wenk and Seelig (55), namely (126 6 4) kJ/
mol for magainin interaction with POPC/POPG membranes.
Nevertheless, we should remember that their membrane
systems are partly negatively charged, so the difference is not
surprising. To the best of our knowledge, our value is the
second value provided in the literature for the enthalpy of
pore formation by antimicrobial peptides.
When setup 3 was used, i.e., titration of liposome sus-
pension into peptide solution (see Materials and Methods),
the results depended again strongly on the lipid system.
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For DMPC, no resolvable peaks were obtainable within
the instrument sensitivity. With the purely negatively charged
system (DMPG), an exothermic process was always ob-
served. Nevertheless, no binding curve was obtained. Con-
sidering that each peptide has a 15.5 charge (5 Lys 1
partially protonated N-terminus), the ‘‘neutralization ratio’’
can be calculated from the P/L (1 charge) mixing stoichi-
ometry. For both studied peptides, the heat release increased
(in absolute value) until charge neutralization, and decreased
rapidly to zero thereafter. In both cases, strong precipitation
occurred when the peptides were mixed with the negatively
charged DMPG at high P/L ratios, albeit more intense and
faster with CA(1–8)M(1–18). Therefore, in the presence of
excess peptide, an a-helix is formed at the negative mem-
brane, and the peptide becomes strongly attached to the
lipids, destroying the membranes and inducing aggregation/
precipitation, as the enthalpy decreases rapidly to zero when
no more peptide is available. A similar interpretation, in the
sense of ‘‘complex formation’’ between peptide and nega-
tively charged membranes, has also been proposed by Lafleur
et al. (56,57) for the interaction of melittin with DMPG,
where the authors suggest that melittin tetramers bridge
two adjacent bilayers, inducing membrane disruption by bi-
layer staking. Further, the authors also indicate that a high
ionic strength (as we have in our systems) promotes self-
aggregation of the peptide (58,59). Similarly, Loura et al.
(60) in a FRET study also suggested that the positively
charged peptides induced membrane disruption and bilayer
stacking in the fluid phase, with the peptide bridging adjacent
bilayers through electrostatic interaction with the anionic
lipid molecules from both bilayers.
In the case of peptide titration with the mixed DMPC/
DMPG (3:1) liposome system, a very interesting result was
obtained. The concentration of the peptides in the cell was
;50 mM, and they were titrated with 35 mM liposome sus-
pensions. An example of the results obtained under these
conditions can be seen in Fig. 5 for the titration of CA(1–
7)M(2–9) with DMPC/DMPG. As seen in the figure, there is
an initial plateau value around (0.19 6 0.02) mJ, followed
by a sigmoidal increase and another plateau at high lipid
contents (the line drawn is just a ‘‘guide for the eye’’ and
does not represent any curve fitting to a model). In the line of
the above reasoning of ‘‘charge neutralization’’, it can be
easily calculated that we are well below the neutralization
ratio for most of the titration curve. It is therefore very in-
teresting to note that the initial plateau value is the same for
both peptides, a result that can be understood if we assume
that at large peptide excess (as we have here at the beginning
of the titration) the behavior is dominated by the attraction
and partition to the negative segments of the membrane. In
fact, we saw that the enthalpy was about the same for the two
peptides, as they partition with helices that span about the
same number of residues. Although our mixed membrane is
considered to be uniform in the absence of the peptide (the
two lipids DMPC and DMPG present ideal mixing), the same
is not truth in its presence, as pointed out by Loura et al. (60)
in their study with another peptide—the positively charged
peptide induces short-range clustering of the anionic lipids. If
we consider, in a simplistic approach, the ratio proposed
above of 1P:5.5L (based only on charges), we can calculate
the enthalpy corresponding to the plateau value of 0.19 mJ
to be 44 kJ/molpep for CA(1–7)M(2–9) and 49 kJ/molpep
for CA(1–8)M(1–18). These values are similar to the en-
thalpies obtained for their interaction with DMPG (42 6 4
and 43 6 4 kJ/mol). The similarity suggests indeed that in
this region, the behavior is dominated by the electrostatic
attraction to the negative parts of the membrane surface, with
a-helix formation, in a process most similar to the interaction
with purely negative membranes. It should be noted that in
most cases in the literature, the plateau region is not observed,
as the peptide concentrations more commonly used lead to
peptide/lipid ratios that are beyond ‘‘charge neutralization’’
(51,61). But when higher peptide concentrations are used, as,
e.g., in Wieprecht et al. (52), where the peptide concentration
was 50 mM, the initial plateau is clearly seen. In our case, as
the amount of lipid increases, the sigmoidal form of the re-
maining curve suggests a region of cooperative partition that
must involve both the negative and zwitterionic parts, until
saturation is reached at ;4% (1:25). Therefore, a treatment
based on a simple partition should not be fully applicable. We
interpret the raising (sigmoidal) part of the curve to reflect
peptide uptake with pore formation, until the threshold value
of 4% (1:25) (based on total lipid, since here we must con-
sider the involvement of both leaflets). A binding coopera-
tivity for CA(1–7)M(2–9) was also observed by Bhargava
and Feix (32), who found it to apparently saturate at;2%. It
is reasonable to expect a higher saturation point in our case as
we have more negatively charged liposomes, as mentioned
above.
FIGURE 4 Heat per injection as a function of peptide percentage (mol/
mol). (n and solid line) Titration of 2.66 mL of CA(1–7)M(2–9) (c ¼ 5.38
mmol/dm3) into DMPC suspension in the vessel (c ¼ 5.85 mmol/dm3). (D
and dotted line) Titration of 12.46 mL of CA(1–7)M(2–9) (c ¼ 2.04 mmol/
dm3) into DMPC suspension in the vessel (c ¼ 31.85 mmol/dm3).
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We should also stress that our TRFS experiments for this
peptide and the membrane DMPC/DPMPG had a very
marked increase in t for low lipid content, which showed a
maximum at 4% (1:25), if we transform the numbers in Fig. 2
to a total lipid content. The similarity of these behaviors and
threshold concentrations is remarkable, and must indeed have
a physical meaning. As regarding TRFS similar measure-
ments, a recent article by Melo and Castanho (62) also re-
vealed the occurrence of maxima in t values for peptide
omiganan interacting with a negative and a partially negative
lipidic system. They also suggest twoKp values, one based on
the initial results (low peptide) and another on the leveling-
off ones, as we did here. They present a very thorough
analysis of their detailed fluorescence results, and propose a
saturation model, as well as further discussing the biological
role of saturation. We believe that in a mixed system, the
superimposition of an initial region of high Kp, followed by
another of lower partition constant as the lipid content in-
creases, reflects the change from a partition mainly to the
negative segments of the membrane followed by partition to
the zwitterionic part of the mixed membrane, with a lower
partition coefficient.
As regarding the Gibbs energy, if we use the values sug-
gested by Ladokhin and White (50) from their study of the
partition of melittin to POPC membranes, we obtain a range
of values for CA(1–7)M(2–9) between 17 and 25 kJ/mol
(for 12 residues) and for CA(1–8)M(1–18) between 22 and
32 kJ/mol (for 10 residues, as 0.40 3 26 ¼ 10). If we
compare these estimates with the DG values in Table 2, we
can see that for CA(1–7)M(2–9), the range of values repre-
sents 61–91% of the total Gibbs energy change for the
DMPG system, and 67–100% for DMPC. As regarding
CA(1–8)M(1–18), the range of values represents 47–69% of
the total Gibbs energy change for the DMPG system, and 50–
74% for DMPC and DMPC/DMPG systems. As Ladokhin
and White (50) also provide a slightly different estimate for
b-sheet partition (2.5 kJ/molres), and our FTIR results in-
dicate that CA(1–8)M(1–18) partitions as a b-sheet to the
DMPC membranes (see below), we did estimate the contri-
bution in this case, which amounts to 25 kJ/mol, i.e., 76%
of the experimental Gibbs energy change.
The estimates based on Wieprecht et al. (51) (partition of
M2a to POPC/POPG) are significantly lower (0.5 kJ/molres).
This is not surprising, as their Gibbs energy values are based
on partition constants that are corrected for electrostatic ef-
fects, i.e., are describing only the hydrophobic component of
the partition (61), being therefore very low for the partially
negative membrane they have studied (K ¼ 50 M1). They
also studied the partition of magainin to POPC membranes and
found a much higher partition constant, namely K  2 3 103
M1. This value will provide an estimate of1.6 kJ/molres for
partition to POPC, a value approaching the lower limit esti-
mate provided by Ladokhin and White (50). If we transform
theirK value (in M1) to a dimensionlessKp value comparable
to ours (both are based on partition to the outer leaflet of the
liposomes), we get the value 2.83 103, in excellent agreement
with our value for the partition of CA(1–7)M(2–9) to DMPC
(see Table 2). The values obtained for Bargava and Feix (32)
for the partition of CA(1–7)M(2–9) to LUVs of POPE/POPG
(8:2) and POPE/POPG/CL (68:26:6) membranes, also at
high ionic strength (20 mM MOPS and 100 mM KCl, pH
7.0), and low P/L ratios, also based on the outer leaflet, are
3.53 103 and 1.43 104 M1. The higher value obtained for
the partition to the second lipid system agrees with its higher
content in anionic lipid (32). Transforming these values to
values comparable to ours, we get 5.0 3 103 and 2.0 3 104.
Our partition constant for this peptide to the mixed system
was difficult to evaluate, but above we provided two values,
one for the initial part of the TRFS titration curve (high P/L
ratios) and another to the final part (lower P/L ratios), 1.0 3
105 and 1.3 3 104, respectively. Bargava and Feix (32) also
observed that there was no linear response in the full con-
centration range, as an upward curvature was observed in the
binding isotherms at relatively low mole fractions of bound
peptide, suggesting a positive cooperativity in the early
stages of membrane binding, exactly as we found by calo-
rimetry and TRFS. As a result, they used only the linear parts
of the plot of Xb ¼ f (Cf) for Kp calculation (appearing at
intermediate concentrations). Our partition constant based at
the end part of our curve is of the same order of magnitude as
the one they obtained for the more negative system, similar to
ours in anionic lipid content (1.3 3 104 vs. 2.0 3 104) and
higher for the value based on the initial points (1.0 3 105).
Taking into account the calculation procedures and the dif-
ferences in lipid type (DMPC instead of DMPE), we believe
that this represents an excellent agreement.
Real-time biospeciﬁc interaction analysis by SPR
SPR analysis did not, unfortunately, contribute significantly
to a further enlightening of the peptide-lipid interaction
FIGURE 5 Heat per injection as a function of injection number for the
titration of DMPC/DMPG (3:1) 35 mM into CA(1–7)M(2–9) (50 mM).
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mechanisms under study. Nevertheless, a qualitative analysis
of the obtained results shows several interesting features.
Typical sensorgrams are displayed in Fig. 6 and show that
specific peptide-lipid interactions do take place and are mod-
ulated by the lipid composition and the peptide, as i), responses
increase along with peptide concentration (Fig. 6 A), and ii),
sensorgrams are distinct for different peptide-lipid pairs (Fig.
6, B–D). The responses (in resonance units) are clearly higher
for CA(1–8)M(1–18), which reflects the higher molecular
weight of this peptide, as compared to its shorter analog,
CA(1–7)M(2–9). The differences between peptide responses
are also influenced by interaction phenomena, as Fig. 6, B–D,
show that the difference in magnitude depends on the lipid
bilayer (note the different scales). If we compare the responses
for both peptides on each model membrane, we can see that on
DMPG surfaces, CA(1–8)M(1–18) displays markedly higher
binding responses than those of CA(1–7)M(2–9) and, further,
although the effect of peptide concentration on response is
significant for the first peptide, it does not affect the response in
the case of the second (Fig. 6 C).
In the case of DMPC bilayers, responses are again higher
for the longer peptide, but differences between peptides are
less marked and the effect of peptide concentration is sim-
ilar for both (Fig. 6 D). Nevertheless, for CA(1–7)M(2–9),
the response reaches a plateau for the concentration 12.5 mM
but not for the higher concentration of 100 mM, as op-
posed with what was observed with DMPG, where a plateau
was reached for both concentrations with resonance units
values that were independent of concentration. For CA(1–
8)M(1–18), the main difference when compared to DMPG
response is that the system never reaches a plateau for the
higher peptide concentration. Finally, on DMPC/DMPG 3:1
surfaces, CA(1–8)M(1–18) still displays higher binding re-
sponses than CA(1–7)M(2–9) and the effect of peptide con-
centration is strong for both peptides, but more accentuated
for the first (Fig. 6 B). Further, the effect of concentration for
CA(1–7)M(2–9) is clearly intermediate on DMPC/DMPG
3:1 as compared to the two previous systems—a concentration
effect on response is clearly observed as in DMPC, but for the
concentration 100 mM, the system is much more close to a
plateau, as observed with DMPG.
If we compare more in detail the observed responses when
the bilayer composition changes, we can see that they are
significantly higher for the DMPG surface for CA(1–8)M(1–
18)—the markedly higher binding responses observed for
this peptide with DMPG indicates that larger amounts are
able to bind to this surface, as compared to DMPC, in the
course of injection of equal peptide concentrations. For
FIGURE 6 Sensorgrams for the interactions, at 35C, of (A) peptide CA(1–7)M(2–9), at six different concentrations, with DMPC/DMPG (3:1); (B) peptides
CA(1–7)M(2–9) (dotted lines) and CA(1–8)M(1–18) (solid lines) with DMPC/DMPG (3:1); (C) peptides CA(1–7)M(2–9) (dotted lines) and CA(1–8)M(1–18)
(solid lines) with DMPG; and (D) peptides CA(1–7)M(2–9) (dotted lines) and CA(1–8)M(1–18) (solid lines) with DMPC.
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CA(1–8)M(2–9), the effect depends strongly on concentration,
whereas for the lower concentration (12.5 mM), the effect is
somewhat larger on DMPG; when the concentration is 100
mM, the response is surprisingly higher with DMPC. That fact,
along with what was referred to above, namely that a plateau is
reached at low concentration but not at 100 mM, probably
indicates that different binding modes occur above and below
a given threshold concentration of CA(1–7)M(2–9).
Another relevant observation was that, in none of the ex-
periments, was it possible to have a complete return of the
response signal to the baseline level at the end of the dissoci-
ation step. The original baseline could never be recovered,
even after extensive rinsing with 10 mM NaOH and 10 mM
HCl (not shown), showing that either a part of the peptides
remained irreversibly bound to the supported lipid bilayer
or that the latter was irreversibly destroyed. This suggests
that very complex phenomena were taking place, where pep-
tide-lipid interactions cannot occur through purely electrostatic
binding, as in such a case, they would be disrupted by the
abrupt changes in pH imposed upon NaOH and HCl injections.
As already mentioned in Materials and Methods, all SPR
analyses were run at two temperatures, 25 and 35C. The
vast majority of SPR real-time analysis of peptide-lipid in-
teractions described in the literature were carried out at 25C
(63–67); however, this temperature is just over the Tm values
for DMPC and DMPG (6), so both gel and liquid crystal
forms will coexist, which implies a significant degree of
structural heterogeneity in the immobilized lipid surface.
Therefore, we decided to run all assays at 35C, well above
the lipids’ Tm, to ensure that the whole lipid surface was in the
liquid crystalline phase, to which the peptides always display
a higher partition. Notwithstanding, we have also run all
assays at 25C, for comparison with previously published
data on similar systems and to ascertain whether a significant
temperature dependence could be observed.
Signal stability was generally superior for experiments run
at 35C, where the curve quality was usually good even for
the lowest peptide concentrations, a situation that was not
verified at 25C. The influence of temperature on binding
responses depended on the injected peptide concentration
(not shown). So, at low peptide concentration, sensorgrams at
either temperature were virtually superimposable in both an-
ionic and zwitterionic surfaces, whereas as peptide concen-
trations were increased, responses became higher at 35C than
at 25C. This effect was more dramatic for DMPG surfaces at
the highest peptide concentration assayed (100 mM).
Despite the complex interaction pattern reflected by the
sensorgrams obtained, quantification of binding kinetics was
attempted. Sensorgrams were generated, at both tempera-
tures, for six different peptide concentrations (3.12–100 mM)
and were tentatively analyzed by curve fitting using all reac-
tion models available in the BIA evaluation software package.
Generally, curve fitting was rather poor to any of the avail-
able models. Worse quality or inclusively nonconvergent fits
were consistently obtained for all peptide-lipid pairs when-
ever the corresponding six sensorgrams (for the six different
concentrations) were simultaneously fitted, according to the
usual procedure (65,68). Convergent and better fittings, with
good chi-squared values, were nevertheless achieved when
each sensorgram was treated separately, but this procedure
yielded unreliable rate constants, as these varied with peptide
concentration. Overall, the results obtained demonstrate that
peptide binding to lipids was too complex to be adequately
described by standard SPR analysis, as this failed to provide
reliable quantification of interaction kinetics, which can be in
turn regarded as a confirmation of the above reasoning based
on TSRF and isothermal titration calorimetry results.
CONCLUDING REMARKS
Our studies show that both peptides interact with the three
lipid systems. Nevertheless, significant differences were
found depending on peptide and membrane system, in line
with our previous findings for these systems, studied with
other techniques (6). The work we presented here allowed us
to get a much more complete picture of the interaction of
these two hybrid peptides with model membranes, as the
energetics, partition, and kinetics of the interaction, as well as
peptide orientation, are addressed.
The perturbation of the lipid bilayers by a peptide is indeed
governed by a balance between electrostatic and hydrophobic
interactions. Our results clearly indicate the importance of
electrostatics in the interaction, suggesting this effect to be
highly responsible for antimicrobial activity and specificity.
In fact, electrostatics is responsible for the initial attraction of
the peptides to the membrane surface, leading to a much
smaller bulk concentration needed for action. Further, as a
consequence of opposite charge, the surface concentration at
a negatively charged surface will be higher than the bulk
concentration, the opposite occurring with zwitterionic
membranes (model for erythrocytes). It was shown here that
CA(1–7)M(2–9) can interact very effectively with DMPC
membranes, but very high concentrations are needed for the
interaction to lead to pore formation. This is in line with the
observed antimicrobial activity—this peptide did not lyse red
blood cells at concentrations .300 mM. On the other hand,
strong evidence was provided for pore formation by this
peptide in intact Escherichia coli cells, with an estimated
pore diameter of 2.2–3.8 nm (69). The results suggest the
pore to be of the toroidal type. Another study suggested also
that the mechanism of action of these peptides was perme-
abilization of the plasma membrane of the pathogen, leading
to bioenergetic collapse and cell death (25). The larger pep-
tide was also shown to have no effect on sheep erythrocytes
(24). This peptide is long enough for its helix to span the
membrane, and it has been shown to require lower concen-
trations for activity permeabilizing the mitochondrial inner
membrane, allowing the movement of both charged and
noncharged solutes (26). Further, it has been shown to have
strong antimicrobial activity against both Gram-positive and
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Gram-negative bacteria (30,31), and has demonstrated high
affinity for lipopolysaccharide, enhancing both outer and
cytoplasmatic membrane permeability (29,70). We believe,
in agreement with the conclusion of Ladhokin and White for
melittin (36) and of Wieprecht et al. for PGLa (52), that the
presence of negatively charged lipids in pathogenic agents is
the key factor for specificity. Further, whereas when there are
only negatively charged lipids (DMPG), the mechanism must
be membrane destruction with bilayer stacking—the inter-
action is very strong and the helices are strongly attached to
the lipids in a ‘‘complex binding’’ stoichiometry, the pres-
ence of zwitterioinic lipids in the mixed membrane brings
‘‘plasticity’’ to the interaction, and even while promoting a
cooperative effect at high peptide ratios, it does not lead only
to membrane destruction and precipitation, allowing a range
of interaction forms to take place depending on P/L ratios. In
this case, our results also suggest the formation of toroidal
pores, in agreement with Pistolesi et al.’s proposal for the
smaller peptide (33). CA(1–8)M(1–18) requires lower con-
centration for action, but its structure is less easy to control
(depends significantly on preparation), and it is highly as-
sociated in buffer. Nevertheless, that might not be critical for
antimicrobial activity, as we found that it could act both in
a-helix and in b-sheet forms. A very recent work showed
these two peptides (CA(1–8)M(1–18) and CA(1–7)M(2–9))
to be active against colistin-resistant clinical strains (28).
In that work, it was shown that the peptides show much
lower minimum inhibitory concentrations than colistin and
have higher affinity toward lipopolysaccharide isolated from
colistin-resistant Acinetobacter baumannii. The authors stress
that they found a strong correlation between LPS affinity and
antimicrobial activity for these peptides. Again, this is in line
with our proposal of a main role for electrostatics in their
antimicrobial action. As regarding CA(1–8)M(1–18), our
results do not allow us such strong conclusions on the pre-
ferred model for the interaction, but we would suggest that
the mechanism might depend on the secondary form present,
which in turn will depend on temperature, pH, and ionic
strength. In any case, if we take together all our results from
this work as well as from our previous study (6), we tend to
think that the final step in antimicrobial action with these
peptides is pore formation and not a detergent-like effect.
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